We have seen 44 institutional investors add shares of $CCAP stock to their portfolio, and 44 decrease their positions in their most recent quarter.
Oppenheimer downgraded Crescent Capital BDC (CCAP) to Perform from Outperform after the business development company lowered its management and incentive fees to support its return on equity. CCAP's ...
Cheap can always get cheaper, and that’s a lesson that I’ve learned in the world of investing many times over. However, sometimes a valuation just gets so low that it starts to look silly. A low ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results